Skip to main content
Year archive

Addex Therapeutics Ltd. — 2023 filings

All 87 regulatory filings released by Addex Therapeutics Ltd. (ADXN) in 2023, sourced directly from the official regulator.

87 Filings
2023 Period
2023 filings (87)
Filing Released Lang
FORM 6-K/A
Foreign Filer Report
2023-12-21 English
FORM 6-K
Foreign Filer Report
2023-12-20 English
Addex Shareholders Approve All Resolutions at Extraordinary General Meeting
AGM Information
2023-12-20 English
FORM 6-K
Foreign Filer Report
2023-12-14 English
Addex Creates Treasury Shares
Share Issue/Capital Change
2023-12-14 English
GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5)
Major Shareholding Notification
2023-12-08 English
424B3
Prospectus
2023-11-30 English
Regulatory Filings 2023
Regulatory Filings
2023-11-30 English
SC 13D/A
Major Shareholding Notification
2023-11-29 English
POS AM
Regulatory Filings
2023-11-29 English
FORM 6-K
Foreign Filer Report
2023-11-29 English
Addex Reports Q3 2023 Financial Results and Provides Corporate Update
Earnings Release Q3 2023
2023-11-29 English
FORM 6-K
Foreign Filer Report
2023-11-28 English
Addex Convenes Extraordinary General Meeting
AGM Information
2023-11-28 English
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023
Report Publication Announcement
2023-11-23 English
FORM 6-K
Foreign Filer Report
2023-11-14 English
Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients
Regulatory Filings
2023-11-14 English
FORM 6-K
Foreign Filer Report
2023-11-08 English
Addex Regains Nasdaq Listing Compliance
Regulatory Filings
2023-11-08 English
Addex Announces Participation in the Bio-Europe 2023 Conference
Regulatory Filings
2023-11-02 English
424B3
Prospectus
2023-10-23 English
FORM 6-K
Foreign Filer Report
2023-10-20 English
Addex Completes ADS Ratio Change
Share Issue/Capital Change
2023-10-20 English
Regulatory Filings 2023
Regulatory Filings
2023-10-06 English
FORM 6-K
Foreign Filer Report
2023-10-06 English
Addex Announces Plan to Implement ADS Ratio Change
Delisting Announcement
2023-10-06 English
FORM 6-K
Foreign Filer Report
2023-09-20 English
Addex mGlu2 NAM Cognition Program Receives €4 Million Grant
Regulatory Filings
2023-09-20 English
Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference
Regulatory Filings
2023-09-06 English
FORM 6-K
Foreign Filer Report
2023-09-05 English
FORM 6-K
Foreign Filer Report
2023-09-05 English
Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024
Regulatory Filings
2023-09-05 English
Addex’s Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain
Regulatory Filings
2023-09-04 English
424B3
Prospectus
2023-08-11 English
Regulatory Filings 2023
Regulatory Filings
2023-08-11 English
POS AM
Regulatory Filings
2023-08-10 English
FORM 6-K
Foreign Filer Report
2023-08-10 English
Addex Reports 2023 Half Year and Second Quarter Financial Results and Provides Corporate Update
Report Publication Announcement H1 2023
2023-08-10 English
Addex Therapeutics to Release Half-Year 2023 Financial Results and Host Conference Call on August 10, 2023
Report Publication Announcement
2023-08-04 English
FORM 6-K
Foreign Filer Report
2023-08-03 English
Addex GABAB Positive Allosteric Modulator Program to Receive Additional CHF2.7 Million from Indivior in Extended Substance Use Disorder Research Collaboration
Regulatory Filings
2023-08-03 English
FORM 6-K
Foreign Filer Report
2023-07-24 English
Addex mGlu2PAM Demonstrates Potential in Substance Use Disorder
Regulatory Filings
2023-07-24 English
FORM 6-K
Foreign Filer Report
2023-06-15 English
Addex Increases Issued Share Capital to Create Treasury Shares
Capital/Financing Update
2023-06-15 English
FORM S-8
Registration Form
2023-06-08 English
Regulatory Filings 2023
Regulatory Filings
2023-06-05 English
424B3
Prospectus
2023-06-02 English
Regulatory Filings 2023
Regulatory Filings
2023-06-01 English
FORM F-1/A
Regulatory Filings
2023-06-01 English
FORM 6-K
Foreign Filer Report
2023-06-01 English
Addex Shareholders Approve All Resolutions at Annual General Meeting
AGM Information
2023-06-01 English
FORM 6-K
Foreign Filer Report
2023-05-18 English
Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Regulatory Filings
2023-05-18 English
Regulatory Filings 2023
Regulatory Filings
2023-05-12 English
Regulatory Filings 2023
Regulatory Filings
2023-05-11 English
F-1/A
Regulatory Filings
2023-05-11 English
FORM 6-K
Foreign Filer Report
2023-05-11 English
Addex Reports Q1 2023 Financial Results and Provides Corporate Update
Earnings Release Q1 2023
2023-05-11 English
FORM 6-K
Foreign Filer Report
2023-05-10 English
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s Independent Interim Review Committee Recommends Continuing Study
Regulatory Filings
2023-05-10 English
Regulatory Filings 2023
Regulatory Filings
2023-05-09 English
FORM 6-K
Foreign Filer Report
2023-05-05 English
Addex Convenes Annual General Meeting 2023
AGM Information
2023-05-05 English
Addex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May 11, 2023
Report Publication Announcement
2023-05-04 English
F-1
Regulatory Filings
2023-05-03 English
Regulatory Filings 2023
Regulatory Filings
2023-04-13 English
GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#4)
Major Shareholding Notification
2023-04-10 English
SC 13D/A
Major Shareholding Notification
2023-04-05 English
Addex Completes $5.0 Million Equity Financing
Share Issue/Capital Change
2023-04-05 English
424B5
Prospectus
2023-04-04 English
FORM 6-K
Foreign Filer Report
2023-04-04 English
FORM 6-K
Foreign Filer Report
2023-04-04 English
Addex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson’s Disease
Regulatory Filings
2023-04-04 English
FORM 6-K
Foreign Filer Report
2023-04-03 English
Addex Raises $5.0 Million in Equity Financing
Share Issue/Capital Change
2023-04-03 English
SC 13D/A
Major Shareholding Notification
2023-03-31 English
FORM 6-K
Foreign Filer Report
2023-03-30 English
FORM 20-F
Annual Report FY 2022
2023-03-30 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-16 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-14 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-14 English
FORM 6-K
Foreign Filer Report
2023-02-09 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-08 English
SC 13G/A
Major Shareholding Notification
2023-02-06 English
FORM 6-K
Foreign Filer Report
2023-02-06 English
FORM 6-K
Foreign Filer Report
2023-01-19 English